Caliper Life Sciences (CALP) Inactive 10-K2005 FY Annual report

Filed: 14 Mar 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: absorption, abstaining, ADME, Allan, Allergy, andin, Anselm, APW, aspect, Australia, Billet, biomarker, bound, broker, Brown, career, Carna, Cassidy, cast, Cerep, choice, clearance, commensurate, Compensationabove, Compensationin, Comstock, convince, correlated, disagree, Duke, encompassin, escrow, excretion, factor, FIFO, flagship, footage, Footnote, fuel, GeneMedicine, GENESEP, GENSEP, Hanover, highlighted, HR, India, Innoveda, Invitrogen, Israel, itsin, IV, Kathryn, kinetic, Korea, lipid, living, Lynch, maker, Malaysia, Manyak, Maryland, MDS, Merrill, metabolism, microelectromechanical, milliliter, momentum, NIAID, NIDA, NIH, NovaScreen, offerin, ofin, onin, opted, optimistic, ordinarily, ourin, panel, Paula, PE, percent, pharma, pharmacological, post, pronouncement, providesin, reallocated, reclassification, remitted, saturation, shortly, show, silico, slightly, South, spectrum, statistical, sublet, Teflon, therapeutic, therapy, toin, tox, toxicology, Tunstall, turnkey, unanticipated, unbilled, unconsolidated, undertaken, unfavorable, unusual, Van, Viewlogic, virtually, Virtusa, vitro, vitroADME, vitroassay, vitroexperimentation, vitroproduct, vitroscreening, vitroTOX, vitrotoxicology, vivo, walkaway, web, withheld, Xenogen, XGEN, yearly, Zoology

Removed: accession, add, Amgen, amounting, ascribed, assistance, balloon, begin, biopharmaceutical, broaden, CA, calling, canceled, cancellation, circumstance, commercialized, compromised, consistently, contractually, controlled, copy, DC, depressed, diminish, easier, electrophoretic, enter, exchanged, exercised, explored, fill, financed, fulfill, fundamental, generating, genomic, harmed, heating, IMAP, industrial, infringed, interface, Internet, lawful, leveraging, Lilly, loan, lost, manipulate, modest, month, NW, organizational, outsource, pertaining, planning, priority, problem, proportionate, reaching, readout, regular, release, renegotiated, renegotiation, repayment, resale, restructure, satisfied, SE, secured, serial, slowdown, standby, structure, submitted, tap, undesirable, useable, utility, vote, Washington

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

CALP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CALIPER LIFE SCIENCES, INC.

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Caliper Life Sciences, Inc (the “Company”) on Form 10-K for the year ended December 31, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas T. Higgins, Executive Vice President and Chief Financial Officer of the Company certify, pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Exchange Act; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


		/s/ THOMAS T. HIGGINS

		Thomas T. Higgins
		Executive Vice President and
		Chief Financial Officer

Date: March 14, 2006